Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
Dow
Colorcon
McKesson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

See Plans and Pricing

« Back to Dashboard

INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-11-07
Court District Court, D. New Jersey Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Madeline Cox Arleo
Jury Demand Plaintiff Referred To Michael A. Hammer
Parties CELGENE CORPORATION; CITY OF PROVIDENCE; DAVID MITCHELL; INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND; INTERNATIONAL UNION OF OPERATING ENGINEERS STATIONARY ENGINEERS LOCAL 39 HEALTH AND WELFARE TRUST FUND; NEW ENGLAND CARPENTERS HEALTH BENEFITS FUND; PHV STANLEY E. FISHER; THALOMID AND REVLIMID ANTITRUST LITIGATION; THALOMID AND REVLIMID ANTITRUST LITIGATION C.A. NO. 2:14-CV-06997-KSH-CLW; THE DETECTIVES' ENDOWMENT ASSOCIATION, INC.
Patents 5,635,517; 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 7,119,106; 7,465,800; 8,288,415; 8,315,886; 8,404,717
Attorneys CHRISTOPHER MICHAEL RUSSO; DANIEL B. REHNS; ERICA G. LANGSEN; FRANK CHARLES CALVOSA; FRANK ROCCO SCHIRRIPA; GAVIN J. ROONEY; JAMES STUART NOTIS; JEFFREY B. GITTLEMAN; JENNIFER SARNELLI; JOHN ANTHONY BLYTH; JOSEPH ALDO FISCHETTI; KATIE ROSE BERAN; NICOLE DENISE BEARCE; WHITNEY ERIN STREET
Firms Barrack Rodos & Bacine; Counsel Not Admitted to Usdc-Nj Bar, Block & Leviton LLP; Gardy & Notis LLP; Gardy & Notis, LLP; Hach Rose Schirripa & Cheverie, LLP; Hausfeld LLP PA; Lowenstein Sandler; Lowenstein Sandler PC; Quinn Emanuel Uquhart & Sullival LLP
Link to Docket External link to docket
Small Molecule Drugs cited in INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-11-07 1 Revlimid (including patent numbers 5,635,517 (the “’517 patent”), 6,281,230 (the “’230 patent”), 6,555,554 …manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…6,315,720 patent, the 6,561,976 patent, the 6,561,977 patent and the 6,755,784 patent (the “Distribution Method…information describing the patent as a “drug product patent” only if the patent claimed the drug product…Method Patents”), and the 8,315,886 patent. The chronological history of these patents is as follows: External link to document
0000-00-00 20 Brief Complaint, IUB only explicitly labels U.S. Patent Nos. 6,045,501, 6,315,720, 6,651,976, 6,561,977, and …three dozen patents, other than the six Distribution Method patents, in its broad patent portfolio covering… Method Patents (Compl. ¶¶ 123-210) – the patent examiner would not have issued the patent claim. See…liable for asserting its patents to preclude generic competition unless the patents in … other patents covering Revlimid and Thalomid were the subject of either fraud on the patent office External link to document
2015-10-29 68 five Distribution Patents, along with Patent No. 5,635,517 (“the ’517 Patent”), Patent No. 6,281,230 (…Revlimid: Patent No. 6,045,501 (“the ’501 Patent”); Patent No. 6,315,720 (“the ’720 Patent”); Patent No. …’976 Patent”); Patent No. 6,561,977 (“the ’977 Patent”); Patent No. 6,755,784 (“the ’784 Patent”); and…230 Patent”), Patent No. 6,555,554 (“the ’554 Patent”), Patent No. 7,119,106 (“the ’106 Patent”), and…obtained: the ’720 Patent in 2001; the ’976 Patent and ’977 Patent in 2003; and the ’784 Patent in 2004. (Id External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Moodys
Express Scripts
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.